RSI's Daniel Krewski - Official portrait

Dr. Daniel Krewski

FSRA, PhD, MHA

Chief Risk Scientist

Joined RSI in 2006

  • Global thought leader in risk science

  • Expert in public and population health

  • 20+ years experience in Federal Government of Canada

  • Professor of epidemiology at University of Ottawa since 1998

  • Research contributions influencing health policy

Dr. Daniel Krewski is Chief Risk Scientist and co-founder of Risk Sciences International (RSI), a firm established in 2006 to bring evidence-based, multidisciplinary expertise to the challenge of understanding, managing, and communicating risk. As RSI’s inaugural CEO and long-time scientific leader, Dr. Krewski helped define the company’s ethos and methodological approach, grounded in rigorous, transparent, and policy-relevant science.

Under his leadership, RSI has become an international reference point in risk science, advising public and private sector organizations on issues ranging from chemical exposure and public health to advanced toxicity testing, infectious disease modeling, and environmental protection. He has served as RSI’s scientific anchor across dozens of high-profile engagements—among them, work for the U.S. Environmental Protection Agency, Health Canada, the Alliance of Blood Operators, and the Pan American Health Organization.

Although now retired as CEO, Dr. Krewski continues in his role as Chief Risk Scientist, where he contributes to RSI’s most complex risk assessment mandates and supports long-term innovation in the company’s scientific strategy. His work at RSI continues to bridge regulatory application with academic inquiry, and he remains a prolific contributor to RSI publications and tools, including frameworks for next-generation toxicity testing and comparative risk modeling.

He has played key roles in RSI projects addressing risks as varied as mad cow disease, carbon capture and storage, air pollution, climate change, neurological disorders, and pandemic influenza. Across these efforts, his expertise in quantitative modeling, risk communication, and structured expert judgment has helped shape not just organizational practices, but international standards in risk evaluation.

Dr. Krewski’s ongoing relationship with academic institutions—particularly the University of Ottawa—has allowed RSI to maintain strong ties to research frontiers. His joint appointments foster a model of knowledge transfer that benefits RSI’s clients and contributes to training the next generation of risk scientists through mentorship, graduate education, and real-world project integration.

Pre-RSI

Daniel Krewski’s pioneering role in the field of risk science began well before the discipline gained formal recognition. Trained first in mathematics, then in statistics, and ultimately in biostatistics with applications in toxicology and epidemiology, his career has always been at the intersection of quantitative analysis and human health. This multidisciplinary pathway reflects the inherently integrative nature of modern risk science.

He began his professional journey in the Federal Government of Canada, where he served for over 20 years, primarily within Health Canada. There, he worked across a spectrum of risk-related domains—food safety, environmental health, toxicological risk evaluation—collaborating with bench scientists, regulatory evaluators, legislative advisors, and public policy experts. These experiences shaped his enduring focus on pragmatic, science-based solutions to protect population health.

In 1998, Dr. Krewski joined the University of Ottawa as a Professor in the School of Epidemiology and Public Health, where he quickly distinguished himself as both a teacher and research leader. At the university, he founded the McLaughlin Centre for Population Health Risk Assessment, modeled after the Harvard Center for Risk Analysis. The Centre became a leading institution for Canadian risk science, fostering national and international collaborations and serving as a hub for innovative methods in risk assessment and management.

During this period, Dr. Krewski was instrumental in helping to develop foundational risk assessment frameworks for both Health Canada and the U.S. Environmental Protection Agency. He contributed to the evolution of regulatory risk practice, building on the insights from landmark efforts like the U.S. National Research Council’s “Red Book” and later publications on toxicity testing and comparative exposure analysis.

His academic initiatives included the creation of Canada’s first graduate program in risk science, providing structured education for a new generation of interdisciplinary risk professionals. He also served as scientific lead or co-lead on numerous large-scale research initiatives and policy collaborations, including systematic reviews on neurological disease, lung cancer burden, and chemical health impacts, and helped structure national responses to emerging risks like bovine spongiform encephalopathy (BSE) and chronic wasting disease.

Through these pre-RSI roles, Dr. Krewski laid much of the groundwork for RSI’s eventual founding, bringing a blend of government experience, academic leadership, and global thought leadership that would come to define the firm’s identity.


Daniel Krewski, in addition to his many hours spent teaching at the University of Ottawa, is regularly asked to speak including this presentation given during the National Cancer Institute Directors' meeting in Lyon.

Case studies associated with Daniel Krewski

Environmental Public Health Approach (EPHA) to Chemicals Expert Workshop

PROJECT DESCRIPTION

To advance the Government of Canada’s Chemicals Management Plan (CMP), a virtual expert workshop was planned and hosted to refine and evaluate a Canadian framework for the Environmental Public Health Approach (EPHA) to chemicals. The initiative focused on developing case...
Read More about Environmental Public Health Approach (EPHA) to Chemicals Expert Workshop

Systematic Review of Artificial Sweeteners and Health Risks

PROJECT DESCRIPTION

A comprehensive systematic review was undertaken to assess experimental evidence regarding the potential health risks associated with artificial sweeteners, specifically focusing on cancer and pre-term delivery. The client sought a rigorous analysis of both in vivo and in vitro experimental...
Read More about Systematic Review of Artificial Sweeteners and Health Risks

Evaluation of Health Product Risk Communication Tools

PROJECT DESCRIPTION

To enhance the effectiveness of health product risk communications, a systematic evaluation was requested to assess the performance of key instruments used to disseminate safety and efficacy information. The aim was to support efforts under the Evaluating the Effectiveness of...
Read More about Evaluation of Health Product Risk Communication Tools

Evaluation of Drug Recall Communication and Risk Determination Processes

PROJECT DESCRIPTION

In response to public and ministerial concerns about the timeliness and adequacy of information shared during a major prescription drug recall, Health Canada commissioned an independent review to assess its response to the event. The situation involved a recall of...
Read More about Evaluation of Drug Recall Communication and Risk Determination Processes

Publications associated with Daniel Krewski

Key characteristics of 86 agents known to cause cancer in humans.


ABSTRACT

Since the inception of the International Agency for Research on Cancer (IARC) in the early 1970s, the IARC Monographs Programme has evaluated more than 1000 agents with respect to carcinogenic hazard; of these, up to and including Volume 119 of...
Publication details about Key characteristics of 86 agents known to cause cancer in humans.

Development of a database on key characteristics of human carcinogens.


ABSTRACT

A database on mechanistic characteristics of human carcinogenic agents was developed by collecting mechanistic information on agents identified as human carcinogens (Group 1) by the International Agency for Research on Cancer (IARC) in the IARC Monographs on the Evaluation of...
Publication details about Development of a database on key characteristics of human carcinogens.

Trends in concomitant clopidogrel and proton pump inhibitor treatment among ACS inpatients, 2000-2016.


ABSTRACT

PURPOSE: The US Food and Drug Administration (FDA) issued three safety announcements between January 2009 and October 2010 warning against concomitant use of clopidogrel and proton pump inhibitors (PPIs) due to a potential drug-drug interaction that may attenuate clopidogrel's antiplatelet...
Publication details about Trends in concomitant clopidogrel and proton pump inhibitor treatment among ACS inpatients, 2000-2016.

Development of a database on tumors and tumor sites in humans and in experimental animals for ‘Group 1 agents identified through volume 109 of the IARC Monographs.


ABSTRACT

Volume 100 in the series of IARC Monographs on the Evaluation of Carcinogenic Risks to Humans comprises an update and review of relevant information on all agents determined to induce cancer in humans. These Group 1 agents are categorized in...
Publication details about Development of a database on tumors and tumor sites in humans and in experimental animals for ‘Group 1 agents identified through volume 109 of the IARC Monographs.

Exposure to loud noise and risk of vestibular schwannoma: results from the INTERPHONE international case‒control study.


ABSTRACT

Objective Studies of loud noise exposure and vestibular schwannomas (VS) have shown conflicting results. The population-based INTERPHONE case‒control study was conducted in 13 countries during 2000-2004. In this paper, we report the results of analyses on the association between VS...
Publication details about Exposure to loud noise and risk of vestibular schwannoma: results from the INTERPHONE international case‒control study.

Conditional validation sampling for consistent risk estimation with binary outcome data subject to misclassification.


ABSTRACT

PURPOSE: Misclassification of a binary outcome can introduce bias in estimation of the odds-ratio associated with an exposure of interest in pharmacoepidemiology research. It has been previously demonstrated that utilizing information from an internal randomly selected validation sample can help...
Publication details about Conditional validation sampling for consistent risk estimation with binary outcome data subject to misclassification.

Concordance between sites of tumor development in humans and in experimental animals for 111 agents that are carcinogenic to humans.


ABSTRACT

Since the inception of the IARC Monographs Programme in the early 1970s, this Programme has developed 119 Monograph Volumes on more than 1000 agents for which there exists some evidence of cancer risk to humans. Of these, 120 agents were...
Publication details about Concordance between sites of tumor development in humans and in experimental animals for 111 agents that are carcinogenic to humans.

Search all publications

RSI News associated with Daniel Krewski

Aging and cognitive decline

Working with the College of Physicians and Surgeons of Alberta, Risk Sciences International conducted a wide-ranging review of aging and cognitive decline, with specific focus on aging physicians and fitness to practice.  The publication in Aging & Mental Health documents domains of cognition that decline with older age, concerns with...
News article about Aging and cognitive decline

Evidence-based Risk Assessment Framework

Working with international thought leaders in risk science, Risk Sciences International investigators contributed to the development of the evidenced-based risk assessment framework shown in the figure below.  The framework evolved from a workshop held at the University of Ottawa in December 2018, jointly organized by the McLaughlin Centre for Population Health Risk...
News article about Evidence-based Risk Assessment Framework

Value of information

Risk Sciences International (RSI) investigators Greg Paoli, Shintaro Hagiwara and Daniel Krewski collaborated with investigators from the US Center for Computational Toxicology and Exposure (CCTE) on the development of an analytical framework to evaluate alternative chemical toxicity testing strategies, meeting a need identified by the US National Research Council in...
News article about Value of information

Quinolones and risk of retinal detachment

Following previous work on the potential risk of acute liver failure associated with quinolone antibiotics, RSI investigators, Mohamed Taher, Franco Momoli, Donald Mattison and Daniel Krewski evaluated the potential risk of retinal detachment (RD) associated with these medications. Although no cases of RD were linked to quinolones in clinical trials, some...
News article about Quinolones and risk of retinal detachment

Bias Assessment in Case-Control and Cohort Studies for Hazard Identification

IARC recently published a volume on quantitative bias modelling: Bias assessment in case–control and cohort studies for hazard identification (IARC Scientific Publication No. 171). We are pleased to see inclusion of some of the work RSI's Drs Franco Momoli and Daniel Krewski conducted for the INTERPHONE and MOBI-Kids studies of...
News article about Bias Assessment in Case-Control and Cohort Studies for Hazard Identification

Outside RSI

Beyond his extraordinary professional accomplishments, Dr. Daniel Krewski is a passionate mentor, energetic speaker, and multitalented individual with a strong connection to both scientific and civic life. Over the course of his career, he has supervised dozens of graduate students and postdoctoral researchers, many of whom have gone on to lead public health, environmental safety, and risk science programs across Canada and internationally.

He remains deeply engaged in the academic community as Scientific Director of the McLaughlin Centre and as a senior member of faculty at the University of Ottawa, where he contributes to program development, scientific advisory boards, and expert panels. He frequently participates in peer-review committees, conference keynote sessions, and collaborative projects with regulatory and research agencies worldwide.

Known for his clarity of thought and collegial manner, Dr. Krewski is often described by colleagues as a principled scientist—someone who communicates with humility, leads through consensus, and uses evidence to advance public well-being.

Yet his interests are far from limited to risk science.

He is a prolific amateur photographer, responsible for documenting RSI’s visual history and for capturing many of the natural stone sculptures and other imagery featured on RSI’s materials and website. His love of photography reflects a lifelong attention to detail and composition—qualities that mirror his scientific mindset.

A resident of Ottawa, Dr. Krewski also enjoys wine tasting, stone sculpture, and performance driving, having participated in programs such as the Ford Performance Racing School in North Carolina. He is equally at home leading a Zumba class on Parliament Hill as he is reviewing national environmental policy; his personal vitality and balance make him a compelling presence across settings.

Through these extracurricular pursuits, Dr. Krewski brings humanity, curiosity, and creativity to everything he does—reinforcing his role not only as a global thought leader in risk science but as a vibrant contributor to Canada’s cultural and academic life.

Teaching Zumba with Co-instructors Sharon and Iryna

A few more images...